Acepromazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Aceprometazine.
Acetophenazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Acetophenazine.
Advertisement
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Sumatriptan.
Almotriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Almotriptan.
Amisulpride
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Amisulpride.
Advertisement
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sumatriptan.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Sumatriptan.
Amphetamine
The serum concentration of Sumatriptan can be increased when it is combined with Amphetamine.
Advertisement
Apalutamide
The serum concentration of Sumatriptan can be decreased when it is combined with Apalutamide.
Aripiprazole
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Aripiprazole.
Asenapine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Asenapine.
Benperidol
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Benperidol.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Sumatriptan.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Sumatriptan.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Sumatriptan.
Brexpiprazole
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Brexpiprazole.
Bromocriptine
Bromocriptine may increase the vasoconstricting activities of Sumatriptan.
Bromperidol
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Bromperidol.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Sumatriptan.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Sumatriptan.
Cariprazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Cariprazine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Chlorprothixene.
Citalopram
The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.
Clomipramine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Clomipramine.
Clozapine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Clozapine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Sumatriptan.
Cyamemazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Cyamemazine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Cyclobenzaprine.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Sumatriptan.
Dapiprazole
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Dapiprazole.
Desipramine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Desipramine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Desvenlafaxine.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Sumatriptan.
Dextromethorphan
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Sumatriptan.
Dihydroergotamine
Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.
Dolasetron
Dolasetron may increase the serotonergic activities of Sumatriptan.
Doxepin
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Doxepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Sumatriptan.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Sumatriptan.
Droperidol
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Droperidol.
Droxidopa
Sumatriptan may increase the hypertensive activities of Droxidopa.
Duloxetine
The risk or severity of adverse effects can be increased when Duloxetine is combined with Sumatriptan.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Sumatriptan.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Sumatriptan.
Eltrombopag
The serum concentration of Sumatriptan can be increased when it is combined with Eltrombopag.
ergoloid mesylates, USP
Ergoloid mesylate may increase the vasoconstricting activities of Sumatriptan.
Ergonovine
Ergonovine may increase the vasoconstricting activities of Sumatriptan.
Ergotamine
Ergotamine may increase the vasoconstricting activities of Sumatriptan.
Escitalopram
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Sumatriptan.
Fentanyl
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Fentanyl.
Fluoxetine
The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.
Flupenthixol
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Fluphenazine.
Fluspirilene
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Fluspirilene.
Fluvoxamine
The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Sumatriptan.
Frovatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Frovatriptan.
Furazolidone
The metabolism of Sumatriptan can be decreased when combined with Furazolidone.
Granisetron
Granisetron may increase the serotonergic activities of Sumatriptan.
Haloperidol
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Haloperidol.
Iloperidone
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Iloperidone.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Sumatriptan.
Iproniazid
The metabolism of Sumatriptan can be decreased when combined with Iproniazid.
Isavuconazole
The serum concentration of Sumatriptan can be increased when it is combined with Isavuconazole.
Isocarboxazid
The serum concentration of Sumatriptan can be increased when it is combined with Isocarboxazid.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Sumatriptan.
Levomilnacipran
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Levomilnacipran.
Linezolid
The risk or severity of adverse effects can be increased when Linezolid is combined with Sumatriptan.
Lithium
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium.
Lorcaserin
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lorcaserin.
Loxapine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Loxapine.
Lurasidone
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lurasidone.
Maprotiline
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Maprotiline.
Mecamylamine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Mecamylamine.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Sumatriptan.
Mesoridazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Mesoridazine.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Sumatriptan.
Methotrimeprazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Methotrimeprazine.
Methylene blue
The serum concentration of Sumatriptan can be increased when it is combined with Methylene blue.
Methylergonovine
Methylergometrine may increase the vasoconstricting activities of Sumatriptan.
Metoclopramide
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Metoclopramide.
Metylperon
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Melperone.
Milnacipran
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Milnacipran.
Minaprine
The metabolism of Sumatriptan can be decreased when combined with Minaprine.
Mirtazapine
The risk or severity of adverse effects can be increased when Mirtazapine is combined with Sumatriptan.
Moclobemide
The serum concentration of Sumatriptan can be increased when it is combined with Moclobemide.
Molindone
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Molindone.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Sumatriptan.
Naratriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Naratriptan.
Nefazodone
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Nefazodone.
Nialamide
The metabolism of Sumatriptan can be decreased when combined with Nialamide.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Sumatriptan.
Olanzapine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Olanzapine.
Ondansetron
Ondansetron may increase the serotonergic activities of Sumatriptan.
Paliperidone
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paliperidone.
Palonosetron
Palonosetron may increase the serotonergic activities of Sumatriptan.
Pargyline
The metabolism of Sumatriptan can be decreased when combined with Pargyline.
Paroxetine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Sumatriptan.
Perazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Perazine.
Periciazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Propericiazine.
Perphenazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Perphenazine.
Phenelzine
The serum concentration of Sumatriptan can be increased when it is combined with Phenelzine.
Pimozide
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Pimozide.
Pipamperone
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Pipotiazine.
Procarbazine
The serum concentration of Sumatriptan can be increased when it is combined with Procarbazine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Prochlorperazine.
Promazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Promethazine.
Prothipendyl
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Prothipendyl.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Sumatriptan.
Quetiapine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Quetiapine.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Sumatriptan.
Rasagiline
The serum concentration of Sumatriptan can be increased when it is combined with Rasagiline.
Remoxipride
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Reserpine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Sumatriptan.
Risperidone
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Risperidone.
Rizatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Rizatriptan.
Rolapitant
The serum concentration of Sumatriptan can be increased when it is combined with Rolapitant.
Selegiline
The serum concentration of Sumatriptan can be increased when it is combined with Selegiline.
Sertindole
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Sertraline.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Sumatriptan.
Sulpiride
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Sulpiride.
Tapentadol
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Tapentadol.
Tedizolid
Tedizolid Phosphate may increase the serotonergic activities of Sumatriptan.
Tedizolid Phosphate
Tedizolid Phosphate may increase the serotonergic activities of Sumatriptan.
Teriflunomide
The serum concentration of Sumatriptan can be increased when it is combined with Teriflunomide.
Thioproperazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Thioproperazine.
Thioridazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Thioridazine.
Thiothixene
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Thiothixene.
Tiapride
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Tiapride.
Toloxatone
The metabolism of Sumatriptan can be decreased when combined with Toloxatone.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Sumatriptan.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Sumatriptan.
Tranylcypromine
The serum concentration of Sumatriptan can be increased when it is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Sumatriptan.
Trifluoperazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Trimipramine.
Tropisetron
Tropisetron may increase the serotonergic activities of Sumatriptan.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Sumatriptan.
Vemurafenib
The serum concentration of Vemurafenib can be decreased when it is combined with Sumatriptan.
Venlafaxine
The risk or severity of adverse effects can be increased when Venlafaxine is combined with Sumatriptan.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Sumatriptan.
Vincristine
The excretion of Vincristine can be decreased when combined with Sumatriptan.
Vortioxetine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Sumatriptan.
Ziprasidone
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Ziprasidone.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sumatriptan.
Zotepine
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Zuclopenthixol.
